Selecta Biosciences has a total of 1021 patents globally, out of which 204 have been granted. Of these 1021 patents, more than 55% patents are active. The USA is where Selecta Biosciences has filed the maximum number of patents, followed by Japan and Australia, it has generated an annual revenue of $0.11 billion in the year 2022. Parallelly, the USA seems to be the main focused R&D center of Selecta Biosciences.
Selecta Biosciences was founded in the year 2007. It is a biopharmaceutical company. As of June 2023, Selecta Biosciences has a market cap of $0.20 Billion.
Do read about some of the most popular patents of Selecta Biosciences which have been covered by us in this article and also you can find Selecta Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Selecta Biosciences patent portfolio.
How many patents does Selecta Biosciences have?
Selecta Biosciences has a total of 1021 patents globally. These patents belong to 84 unique patent families. Out of 1021 patents, 568 patents are active.
How Many Patents did Selecta Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Selecta Biosciences Applications Filed | Selecta Biosciences Patents Granted |
| 2022 | 40 | 24 |
| 2021 | 59 | 37 |
| 2020 | 74 | 28 |
| 2019 | 54 | 19 |
| 2018 | 38 | 31 |
| 2017 | 78 | 21 |
| 2016 | 9 | 18 |
| 2015 | 144 | 7 |
| 2014 | 114 | 3 |
| 2013 | 31 | 2 |
| 2012 | 204 | – |
| 2011 | 110 | – |
How many Selecta Biosciences patents are Alive/Dead?
Worldwide Patents
How Many Patents did Selecta Biosciences File in Different Countries?
Countries in which Selecta Biosciences Filed Patents
| Country | Patents |
| United States Of America | 120 |
| Japan | 118 |
| Australia | 110 |
| China | 107 |
| Israel | 82 |
| Korea (South) | 80 |
| Mexico | 69 |
| Europe | 64 |
| Canada | 54 |
| Brazil | 50 |
| India | 39 |
| Germany | 8 |
| Spain | 8 |
| Denmark | 7 |
| Hungary | 5 |
| Hong Kong (S.A.R.) | 4 |
| Poland | 3 |
| Italy | 3 |
| Norway | 2 |
| Portugal | 2 |
| Lithuania | 1 |
| Serbia | 1 |
| Croatia | 1 |
| Slovenia | 1 |
Where are Research Centres of Selecta Biosciences Patents Located?
10 Best Selecta Biosciences Patents
US20120301498A1 is the most popular patent in the Selecta Biosciences portfolio. It has received 440 citations so far from companies like Abbvie, The General Hospital Corporation, and Ethicon.
Below is the list of 10 most cited patents of Selecta Biosciences:
| Publication Number | Citation Count |
| US20120301498A1 | 440 |
| US20110262491A1 | 182 |
| WO2012149259A1 | 162 |
| US20100303850A1 | 146 |
| US20110020388A1 | 141 |
| WO2012149411A1 | 124 |
| US8652487B2 | 121 |
| US20120171229A1 | 117 |
| US20120244222A1 | 104 |
| US20110293701A1 | 104 |
What are Selecta Biosciences’ key innovation segments?
What Technologies are Covered by Selecta Biosciences?
The chart below distributes patents filed by Selecta Biosciences